KIDNEY FOUNDATION FOR CHILDREN
SAVING YOUNG LIVES
Questions racing in my mind were
1.Should Tanzil be advised to opt for longterm maintenance dialysis?
2.Can he undergo renal transplantation?
3.What are his chances of graft and patient survival?
4. What was his risk of hepatic decompensation?
1. .Pipli CL, Paptheodoridis GV, Evangelos C,Cholongitas EC.Treatment of hepatitis B in patients with chronic kidney disease.Kidney International (2013),84.880-885
2. Kidney Disease Improving Global Outcomes(KDIGO) Transplant work group.KDIGO clinical practice guidelines
for the care of kidney transplant recepients.Am J Transpalnt (2009) 9(suppl 3) S 19-20
from one fellow to another
What I learnt about kidney transplantation in a
HBxAg +ve child with ESRD
I should have known better than ask my Boss these questions in the midst of the busy OPD.. I was promptly asked to read up and present a seminar in the weekly meet.These were some of the good articles that I reviewed.
ENTECAVIR DOSE ONCE DAILY
10 -11 kg 0.15 mg ( 3ml)
11-14 kg 0.2mg ( 4 mi
14 - 17 kg 0.25 mg (5ml)
17 - 20 kg 0.3 mg ( 6 ml )
20-23 kg 0.35 mg (7 ml )
26-30 kg 0.4 mg ( 9 ml )
> 30 kg 0.5 mg ( 10 ml)) or 1 tab 0.5 mg
eGFR 15 - 30 ml / min
Initial 4 mg / kg
Maintenance 2.5 mg/kg
Dr. Arpana Hanchinmani